NANOVIRICIDES, INC. Adjustments to Additional Paid in Capital, Warrant Issued
NANOVIRICIDES, INC. (NNVC) reported Adjustments to Additional Paid in Capital, Warrant Issued of $53.50 thousand for the 12-month period ending 2018-06-30, per its 10-K filed 2020-10-13.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2020-10-13
- NANOVIRICIDES, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2014-03-31 was $0.00.
- NANOVIRICIDES, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2013-12-31 was $0.00.
- NANOVIRICIDES, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2013-09-30 was $113.70K.
- NANOVIRICIDES, INC. adjustments to additional paid in capital, warrant issued for fiscal 2018 was $53.50K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 0 month | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|---|
| 2018-06-30 | $53.50K 10-K · filed 2020-10-13 | ||||
| 2014-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-15 | $0.00 derived: sum of 2 quarters · filed 2014-05-15 | $113.70K 10-Q · filed 2014-05-15 | ||
| 2013-12-31 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-02-14 | $113.70K 10-Q · filed 2014-02-14 | |||
| 2013-09-30 | $113.70K 10-Q/A · filed 2013-11-18 | ||||
| 2013-09-09 | $113.70K 10-K · filed 2015-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |